<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>P. Gingivalis on Quiet Inflammation</title>
    <link>https://www.quietinflammation.com/tags/p.-gingivalis/</link>
    <description>Recent content in P. Gingivalis on Quiet Inflammation</description>
    <image>
      <title>Quiet Inflammation</title>
      <url>https://www.quietinflammation.com/images/banner.jpg</url>
      <link>https://www.quietinflammation.com/images/banner.jpg</link>
    </image>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 11 Jul 2026 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.quietinflammation.com/tags/p.-gingivalis/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Gingipain Inhibitors: The Alzheimer&#39;s Drug That Failed and Was Reborn</title>
      <link>https://www.quietinflammation.com/posts/gut-health/gingipain-alzheimer-spring-trial-2026/</link>
      <pubDate>Sat, 11 Jul 2026 00:00:00 +0000</pubDate>
      <guid>https://www.quietinflammation.com/posts/gut-health/gingipain-alzheimer-spring-trial-2026/</guid>
      <description>A drug targeting oral bacteria in the brain failed, then a new company picked it up. What the gingipain inhibitor story reveals about Alzheimer&amp;#39;s.</description>
    </item>
    <item>
      <title>Gum Bacteria and Alzheimer&#39;s: The New Drug Target</title>
      <link>https://www.quietinflammation.com/posts/gut-health/gingipain-inhibitor-alzheimer-oral-bacteria/</link>
      <pubDate>Fri, 10 Jul 2026 00:00:00 +0000</pubDate>
      <guid>https://www.quietinflammation.com/posts/gut-health/gingipain-inhibitor-alzheimer-oral-bacteria/</guid>
      <description>Pharmaceutical researchers are developing drugs that target oral bacteria in the brain to treat Alzheimer&amp;#39;s. Here&amp;#39;s what the science shows.</description>
    </item>
  </channel>
</rss>
